• Expert Guidance
  • Get Help
  • Patient Stories
  • About Us
    • Our Story
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Support Our Mission
  • Expert Guidance
  • Get Help
  • Patient Stories
  • About Us
    • Our Story
    • Meet the Team that Cares
    • Distinguished Advisors
    • Our Partners
    • Support Our Services
    • Talk to Us
    • Financial Documents
  • Support Our Mission
 

10 Years in CLL: Top Advances From 2012-2022

July 13, 2022
Focus: Leukemia
Topics: Treatment Options

Published by Targeted Therapies in Oncology for healthcare professionals, this article outlines how novel targeted therapies have largely replaced chemotherapy and prolonged life greatly for people with chronic lymphocytic leukemia (CLL).

.

Tags: chronic lymphocytic leukemia, CLL, targeted therapy

Our Mission: Cancer Commons is a non-profit network of patients, scientists, and physicians united by a shared goal—to optimize each patient’s outcome and maximize collective learning to benefit the next patient.

Don’t miss Cancer Commons Connects
Insights and stories—from and for our community

Working.

Our Services

  • Expert Guidance
  • Register with Cancer Commons

Learn More

  • About Your Cancer
  • Curious Dr. George
  • Patient Stories & Outcomes
  • Testimonials

About Us

  • Our Story
  • Our Team
  • Board of Directors
  • Partners
  • Careers
  • Financial Documents
  • Contact Us

Support & Giving

  • Contribute Now
  • Support Expert Guidance for Cancer Patients


Donate

Cancer Commons
2625 Middlefield Road Suite 104
Palo Alto, CA 94306

650-289-4044

Patient Hotline

877-971-1200

  • Privacy Policy

© 2025 Cancer Commons.